<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39334918</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2218-273X</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>Biomolecules</Title><ISOAbbreviation>Biomolecules</ISOAbbreviation></Journal><ArticleTitle>Chitosan-Modified AgNPs Efficiently Inhibit Swine Coronavirus-Induced Host Cell Infections via Targeting the Spike Protein.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1152</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biom14091152</ELocationID><Abstract><AbstractText>The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has filled a gap in our knowledge regarding the prevention of CoVs. Swine coronavirus (CoV) is a significant pathogen that causes huge economic losses to the global swine industry. Until now, anti-CoV prevention and control have been challenging due to the rapidly generated variants. Silver nanoparticles (AgNPs) with excellent antimicrobial activity have attracted great interest for biosafety prevention and control applications. In this study, we synthesized chitosan-modified AgNPs (Chi-AgNPs) with good biocompatibility to investigate their antiviral effects on swine CoVs. In vitro assays showed that Chi-AgNPs could significantly impaired viral entry. The direct interaction between Chi-AgNPs and CoVs can destroy the viral surface spike (S) protein secondary structure associated with viral membrane fusion, which is caused by the cleavage of disulfide bonds in the S protein. Moreover, the mechanism showed that Chi-AgNPs reduced the virus-induced apoptosis of Vero cells via the ROS/p53 signaling activation pathway. Our data suggest that Chi-AgNPs can serve as a preventive strategy for CoVs infection and provide a molecular basis for the viricidal effect of Chi-AgNPs on CoVs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dongliang</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>College of Biology, Hunan University, Changsha 410082, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Provincial Key Laboratory of Protein Engineering in Animal Vaccines, College of Veterinary Medicine, Hunan Agricultural University, Changsha 410128, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Caiyun</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>College of Biology, Hunan University, Changsha 410082, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Yihan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Hunan Provincial Key Laboratory of Protein Engineering in Animal Vaccines, College of Veterinary Medicine, Hunan Agricultural University, Changsha 410128, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Mingxia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hunan Provincial Key Laboratory of Protein Engineering in Animal Vaccines, College of Veterinary Medicine, Hunan Agricultural University, Changsha 410128, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Naidong</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Hunan Provincial Key Laboratory of Protein Engineering in Animal Vaccines, College of Veterinary Medicine, Hunan Agricultural University, Changsha 410128, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tong</LastName><ForeName>Chunyi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>College of Biology, Hunan University, Changsha 410082, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-2502-1011</Identifier><AffiliationInfo><Affiliation>Hunan Provincial Key Laboratory of Protein Engineering in Animal Vaccines, College of Veterinary Medicine, Hunan Agricultural University, Changsha 410128, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>College of Biology, Hunan University, Changsha 410082, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2023M741130</GrantID><Agency>China Postdoctoral Science Foundation</Agency><Country /></Grant><Grant><GrantID>2023JJ40134</GrantID><Agency>Hunan Provincial Natural Science Foundation of China</Agency><Country /></Grant><Grant><GrantID>32172844</GrantID><Agency>National Natural Science Foundation of China</Agency><Country /></Grant><Grant><GrantID>2021NK1030</GrantID><Agency>Hunan Province Technology Breakthrough Project of 2021 for the open competition mechanism to select the best candidates</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomolecules</MedlineTA><NlmUniqueID>101596414</NlmUniqueID><ISSNLinking>2218-273X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9012-76-4</RegistryNumber><NameOfSubstance UI="D048271">Chitosan</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>3M4G523W1G</RegistryNumber><NameOfSubstance UI="D012834">Silver</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048271" MajorTopicYN="Y">Chitosan</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="Y">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053768" MajorTopicYN="Y">Metal Nanoparticles</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012834" MajorTopicYN="Y">Silver</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="Y">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013552" MajorTopicYN="N">Swine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053586" MajorTopicYN="N">Virus Internalization</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ROS/p53 signaling pathway</Keyword><Keyword MajorTopicYN="N">chitosan</Keyword><Keyword MajorTopicYN="N">coronavirus</Keyword><Keyword MajorTopicYN="N">disulfide bonds</Keyword><Keyword MajorTopicYN="N">silver nanoparticles</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39334918</ArticleId><ArticleId IdType="pmc">PMC11430280</ArticleId><ArticleId IdType="doi">10.3390/biom14091152</ArticleId><ArticleId IdType="pii">biom14091152</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lozano R., Naghavi M., Foreman K., Lim S., Shibuya K., Aboyans V., Abraham J., Adair T., Aggarwal R., Ahn S.Y., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–2128. doi: 10.1016/S0140-6736(12)61728-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)61728-0</ArticleId><ArticleId IdType="pmc">PMC10790329</ArticleId><ArticleId IdType="pubmed">23245604</ArticleId></ArticleIdList></Reference><Reference><Citation>Du T., Zhang J., Li C., Song T., Li P., Liu J., Du X., Wang S. Gold/Silver hybrid Nanoparticles with enduring inhibition of coronavirus multiplication through multisite mechanisms. Bioconjugate Chem. 2020;31:2553–2563. doi: 10.1021/acs.bioconjchem.0c00506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.bioconjchem.0c00506</ArticleId><ArticleId IdType="pubmed">33073571</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahony J.B. Detection of respiratory viruses by molecular methods. Clin. Microbiol. Rev. 2008;21:716–747. doi: 10.1128/CMR.00037-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00037-07</ArticleId><ArticleId IdType="pmc">PMC2570148</ArticleId><ArticleId IdType="pubmed">18854489</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D., Wu T., Liu Q., Yang Z. The SARS-CoV-2 outbreak: What we know. Int. J. Infect. Dis. 2020;94:44–48. doi: 10.1016/j.ijid.2020.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.03.004</ArticleId><ArticleId IdType="pmc">PMC7102543</ArticleId><ArticleId IdType="pubmed">32171952</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J.T., Leung K., Leung G.M. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: A modelling study. Lancet. 2020;395:689–697. doi: 10.1016/S0140-6736(20)30260-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30260-9</ArticleId><ArticleId IdType="pmc">PMC7159271</ArticleId><ArticleId IdType="pubmed">32014114</ArticleId></ArticleIdList></Reference><Reference><Citation>Alphandéry E. The potential of various nanotechnologies for coronavirus diagnosis/treatment highlighted through a literature analysis. Bioconjugate Chem. 2020;31:1873–1882. doi: 10.1021/acs.bioconjchem.0c00287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.bioconjchem.0c00287</ArticleId><ArticleId IdType="pubmed">32639742</ArticleId></ArticleIdList></Reference><Reference><Citation>Turlewicz-Podbielska H., Pomorska-Mól M. Porcine coronaviruses: Overview of the state of the art. Virol. Sin. 2021;36:833–851. doi: 10.1007/s12250-021-00364-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-021-00364-0</ArticleId><ArticleId IdType="pmc">PMC7959302</ArticleId><ArticleId IdType="pubmed">33723809</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Vlasova A.N., Kenney S.P., Saif L.J. Emerging and re-emerging coronaviruses in pigs. Curr. Opin. Virol. 2019;34:39–49. doi: 10.1016/j.coviro.2018.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2018.12.001</ArticleId><ArticleId IdType="pmc">PMC7102852</ArticleId><ArticleId IdType="pubmed">30654269</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Wang H.Y. Porcine enteric coronaviruses: An updated overview of the pathogenesis, prevalence, and diagnosis. Vet. Res. Commun. 2021;45:75–86. doi: 10.1007/s11259-021-09808-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11259-021-09808-0</ArticleId><ArticleId IdType="pmc">PMC8273569</ArticleId><ArticleId IdType="pubmed">34251560</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerdts V., Zakhartchouk A. Vaccines for porcine epidemic diarrhea virus and other swine coronaviruses. Vet. Microbiol. 2017;206:45–51. doi: 10.1016/j.vetmic.2016.11.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2016.11.029</ArticleId><ArticleId IdType="pmc">PMC7117160</ArticleId><ArticleId IdType="pubmed">27964998</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C.M., Saif L.J., Marthaler D., Wang Q. Evolution, antigenicity and pathogenicity of global porcine epidemic diarrhea virus strains. Virus Res. 2016;226:20–39. doi: 10.1016/j.virusres.2016.05.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2016.05.023</ArticleId><ArticleId IdType="pmc">PMC7111424</ArticleId><ArticleId IdType="pubmed">27288724</ArticleId></ArticleIdList></Reference><Reference><Citation>He W.T., Bollen N., Xu Y., Zhao J., Dellicour S., Yan Z., Gong W., Zhang C., Zhang L., Lu M., et al. Phylogeography reveals association between swine trade and the spread of porcine epidemic diarrhea virus in China and across the world. Mol. Biol. Evol. 2022;39:msab364. doi: 10.1093/molbev/msab364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msab364</ArticleId><ArticleId IdType="pmc">PMC8826572</ArticleId><ArticleId IdType="pubmed">34951645</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Z., Kong N., Zhang X., Liu Y., Hu P., Mou S., Liljeström P., Shi J., Tan W., Kim J.S., et al. A materials-science perspective on tackling COVID-19. Nat. Rev. Mater. 2020;5:847–860. doi: 10.1038/s41578-020-00247-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41578-020-00247-y</ArticleId><ArticleId IdType="pmc">PMC7556605</ArticleId><ArticleId IdType="pubmed">33078077</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull R.A., Adikari T.N., Ferguson J.M., Hammond J.M., Stevanovski I., Beukers A.G., Naing Z., Yeang M., Verich A., Gamaarachchi H., et al. Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis. Nat. Commun. 2020;11:6272. doi: 10.1038/s41467-020-20075-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20075-6</ArticleId><ArticleId IdType="pmc">PMC7726558</ArticleId><ArticleId IdType="pubmed">33298935</ArticleId></ArticleIdList></Reference><Reference><Citation>Mushtaq A., Iqbal M.Z., Kong X. Antiviral effects of coinage metal-based nanomaterials to combat COVID-19 and its variants. J. Mater. Chem. B. 2022;10:5323–5343. doi: 10.1039/D2TB00849A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D2TB00849A</ArticleId><ArticleId IdType="pubmed">35775993</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Yeom M., Lee T., Kim H.O., Na W., Kang A., Lim J.W., Park G., Park C., Song D., et al. Porous gold nanoparticles for attenuating infectivity of influenza A virus. J. Nanobiotechnol. 2020;18:54. doi: 10.1186/s12951-020-00611-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12951-020-00611-8</ArticleId><ArticleId IdType="pmc">PMC7092597</ArticleId><ArticleId IdType="pubmed">32209114</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori Y., Ono T., Miyahira Y., Nguyen V.Q., Matsui T., Ishihara M. Antiviral activity of silver nanoparticle/chitosan composites against H1N1 influenza A virus. Nanoscale Res. Lett. 2013;8:93. doi: 10.1186/1556-276X-8-93.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1556-276X-8-93</ArticleId><ArticleId IdType="pmc">PMC3606407</ArticleId><ArticleId IdType="pubmed">23421446</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X.X., Li C.M., Huang C.Z. Curcumin modified silver nanoparticles for highly efficient inhibition of respiratory syncytial virus infection. Nanoscale. 2016;8:3040–3048. doi: 10.1039/C5NR07918G.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C5NR07918G</ArticleId><ArticleId IdType="pubmed">26781043</ArticleId></ArticleIdList></Reference><Reference><Citation>Lara H.H., Ayala-Nuñez N.V., Ixtepan-Turrent L., Rodriguez-Padilla C. Mode of antiviral action of silver nanoparticles against HIV-1. J. Nanobiotechnol. 2010;8:1. doi: 10.1186/1477-3155-8-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-3155-8-1</ArticleId><ArticleId IdType="pmc">PMC2818642</ArticleId><ArticleId IdType="pubmed">20145735</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu L., Sun R.W., Chen R., Hui C.K., Ho C.M., Luk J.M., Lau G.K., Che C.M. Silver nanoparticles inhibit hepatitis B virus replication. Antivir. Ther. 2008;13:253–262. doi: 10.1177/135965350801300210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/135965350801300210</ArticleId><ArticleId IdType="pubmed">18505176</ArticleId></ArticleIdList></Reference><Reference><Citation>Orlowski P., Tomaszewska E., Gniadek M., Baska P., Nowakowska J., Sokolowska J., Nowak Z., Donten M., Celichowski G., Grobelny J., et al. Tannic acid modified silver nanoparticles show antiviral activity in herpes simplex virus type 2 infection. PLoS ONE. 2014;9:e104113. doi: 10.1371/journal.pone.0104113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0104113</ArticleId><ArticleId IdType="pmc">PMC4130517</ArticleId><ArticleId IdType="pubmed">25117537</ArticleId></ArticleIdList></Reference><Reference><Citation>Du T., Lu J., Liu L., Dong N., Fang L., Xiao S., Han H. Antiviral Activity of graphene oxide-silver nanocomposites by preventing viral entry and activation of the antiviral innate immune response. ACS Appl. Bio Mater. 2018;1:1286–1293. doi: 10.1021/acsabm.8b00154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsabm.8b00154</ArticleId><ArticleId IdType="pubmed">34996232</ArticleId></ArticleIdList></Reference><Reference><Citation>Milić M., Leitinger G., Pavičić I., Zebić Avdičević M., Dobrović S., Goessler W., Vinković Vrček I. Cellular uptake and toxicity effects of silver nanoparticles in mammalian kidney cells. J. Appl. Toxicol. 2015;35:581–592. doi: 10.1002/jat.3081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jat.3081</ArticleId><ArticleId IdType="pubmed">25352480</ArticleId></ArticleIdList></Reference><Reference><Citation>He Q., Lu J., Liu N., Lu W., Li Y., Shang C., Li X., Hu L., Jiang G. Antiviral properties of silver nanoparticles against SARS-CoV-2: Effects of surface coating and particle size. Nanomaterials. 2022;12:990. doi: 10.3390/nano12060990.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nano12060990</ArticleId><ArticleId IdType="pmc">PMC8950764</ArticleId><ArticleId IdType="pubmed">35335803</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Wang J., Liu Y., Luo X., Lei W., Xie L. Antiviral and virucidal effects of curcumin on transmissible gastroenteritis virus in vitro. J. Gen. Virol. 2020;101:1079–1084. doi: 10.1099/jgv.0.001466.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.001466</ArticleId><ArticleId IdType="pubmed">32677610</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazdi F., Anbia M., Sepehrian M. Recent advances in removal of inorganic anions from water by chitosan-based composites: A comprehensive review. Carbohydr. Polym. 2023;320:121230. doi: 10.1016/j.carbpol.2023.121230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carbpol.2023.121230</ArticleId><ArticleId IdType="pubmed">37659817</ArticleId></ArticleIdList></Reference><Reference><Citation>Eltaweil A.S., Omer A.M., El-Aqapa H.G., Gaber N.M., Attia N.F., El-Subruiti G.M., Mohy-Eldin M.S., Abd El-Monaem E.M. Chitosan based adsorbents for the removal of phosphate and nitrate: A critical review. Carbohydr. Polym. 2021;274:118671. doi: 10.1016/j.carbpol.2021.118671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carbpol.2021.118671</ArticleId><ArticleId IdType="pubmed">34702487</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D., Gao X., Huang X., Liu P., Xiong W., Wu S., Hao F., Luo H. Preparation of organic-inorganic chitosan@silver/sepiolite composites with high synergistic antibacterial activity and stability. Carbohydr. Polym. 2020;249:116858. doi: 10.1016/j.carbpol.2020.116858.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carbpol.2020.116858</ArticleId><ArticleId IdType="pubmed">32933687</ArticleId></ArticleIdList></Reference><Reference><Citation>Belouzard S., Millet J.K., Licitra B.N., Whittaker G.R. Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses. 2012;4:1011–1033. doi: 10.3390/v4061011.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v4061011</ArticleId><ArticleId IdType="pmc">PMC3397359</ArticleId><ArticleId IdType="pubmed">22816037</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai M., Deshmukh S.D., Ingle A.P., Gupta I.R., Galdiero M., Galdiero S. Metal nanoparticles: The protective nanoshield against virus infection. Crit. Rev. Microbiol. 2016;42:46–56. doi: 10.3109/1040841X.2013.879849.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/1040841X.2013.879849</ArticleId><ArticleId IdType="pubmed">24754250</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrapp D., McLellan J.S. The 3.1-Angstrom cryo-electron microscopy structure of the porcine epidemic diarrhea virus spike protein in the prefusion conformation. J. Virol. 2019;93:e00919–e00923. doi: 10.1128/JVI.00923-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00923-19</ArticleId><ArticleId IdType="pmc">PMC6854500</ArticleId><ArticleId IdType="pubmed">31534041</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., van Kuppeveld F.J.M., He Q., Rottier P.J.M., Bosch B.J. Cellular entry of the porcine epidemic diarrhea virus. Virus Res. 2016;226:117–127. doi: 10.1016/j.virusres.2016.05.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2016.05.031</ArticleId><ArticleId IdType="pmc">PMC7114534</ArticleId><ArticleId IdType="pubmed">27317167</ArticleId></ArticleIdList></Reference><Reference><Citation>Grishin A.M., Dolgova N.V., Landreth S., Fisette O., Pickering I.J., George G.N., Falzarano D., Cygler M. Disulfide bonds play a critical role in the structure and function of the receptor-binding domain of the SARS-CoV-2 spike antigen. J. Mol. Biol. 2022;434:167357. doi: 10.1016/j.jmb.2021.167357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2021.167357</ArticleId><ArticleId IdType="pmc">PMC8588607</ArticleId><ArticleId IdType="pubmed">34780781</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X., Xu Y., Zhang Q., Yang F., Yin Z., Wang L., Li Q. Porcine epidemic diarrhea virus infections induce apoptosis in Vero cells via a reactive oxygen species (ROS)/p53, but not p38 MAPK and SAPK/JNK signalling pathways. Vet. Microbiol. 2019;232:1–12. doi: 10.1016/j.vetmic.2019.03.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2019.03.028</ArticleId><ArticleId IdType="pmc">PMC7117205</ArticleId><ArticleId IdType="pubmed">31030832</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.M., Burrough E. The Effects of swine coronaviruses on ER stress, autophagy, apoptosis, and alterations in cell morphology. Pathogens. 2022;11:940. doi: 10.3390/pathogens11080940.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11080940</ArticleId><ArticleId IdType="pmc">PMC9416022</ArticleId><ArticleId IdType="pubmed">36015060</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Lin Z., Guo M., Zhao M., Xia Y., Wang C., Xu T., Zhu B. Inhibition of H1N1 influenza virus-induced apoptosis by functionalized selenium nanoparticles with amantadine through ROS-mediated AKT signaling pathways. Int. J. Nanomed. 2018;13:2005–2016. doi: 10.2147/IJN.S155994.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJN.S155994</ArticleId><ArticleId IdType="pmc">PMC5892959</ArticleId><ArticleId IdType="pubmed">29662313</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Wang C., Shu J., Feng H., He Y., Chen J., Shu J. Porcine epidemic diarrhea virus induces Vero cell apoptosis via the p53-PUMA signaling pathway. Viruses. 2021;13:1218. doi: 10.3390/v13071218.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13071218</ArticleId><ArticleId IdType="pmc">PMC8310168</ArticleId><ArticleId IdType="pubmed">34202551</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang X., Foldbjerg R., Miclaus T., Wang L., Singh R., Hayashi Y., Sutherland D., Chen C., Autrup H., Beer C. Multi-platform genotoxicity analysis of silver nanoparticles in the model cell line CHO-K1. Toxicol. Lett. 2013;222:55–63. doi: 10.1016/j.toxlet.2013.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.toxlet.2013.07.011</ArticleId><ArticleId IdType="pubmed">23872614</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>